|
|
Comparison of Efficacy and Side Effects between Oxaliplatin Combined with Capecitabine and ECF regimen in the Treatment of Advanced Gastric Cancer |
WENG Jian-ying, WANG Hui, LI Xue-feng |
Department of Pharmacy, Maternity and Child Care of Meishan City, Sichuan Province 620010 |
|
|
Abstract 【Objective】 To compare the curative effect and toxicity of two adjuvant chemotherapy regimens: oxaliplatin with capecitabine vs ECF regimen (epirubicin + cisplatin + leucovorin + fluorouracil) in the treatment of patients with advanced gastric cancer. 【Methods】A total of 100 patients with advanced gastric cancer were randomly divided into the control group who underwent the ECF regimen and the observation group who received oxaliplatin combined with capecitabine. There were 50 patients in each group. The efficacy and side effects of the two regimen treatments between the two groups were compared. 【Results】The total effective rate in the observation group was 78% (39/50), slightly higher than 70% (35/50) in the control group. However, there was no significant difference between the two groups (P>0.05). The incidence of toxic side effects was significantly lower in the observation group than in the control group and the difference was significant (P<0.05).【Conclusion】The efficacy of oxaliplatin combined with capecitabine regimen in the treatment of advanced gastric cancer is similar to that of the ECF regimen. However, the patient's tolerance is good, the hospitalization time is short, and the adverse reactions are mild. Patients have good compliance and high quality of life. It is worthy of clinical recommendation.
|
Received: 06 May 2017
|
|
|
|
|
[1] 高辉, 丁鑫, 魏东,等. 多西他赛对比表柔比星联合顺铂、亚叶酸钙和氟尿嘧啶一线治疗进展期胃癌的随机对照研究[J].临床肿瘤学杂志, 2010, 15(6):529-533. [2] 曾德余, 殷先利, 邬麟,等. 替吉奥胶囊联合顺铂、多西紫杉醇治疗晚期胃癌的临床观察[J].医学临床研究, 2011, 28(1):130-131. [3] Jeong J, Lim SM, Yun JY,et al.Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric Cancer[J].Oncology,2012, 83(5):292-9. [4] 周和平, 李奕, 赵焕堂. 奥沙利铂联合5-氟尿嘧啶和亚叶酸钙治疗复发性胃癌疗效观察[J].广西医学, 2006, 28(8):1221-1222. [5] Zhou K, Wen F, Zhang P,et al.Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer[J].Clin Transla Oncol,2017,22(17):1-8. [6] 节阳华, 帕提玛?阿布力米提, 谢新梅,等. 卡培他滨联合奥沙利铂治疗进展期胃癌的近期疗效及对生活质量的影响[J].实用临床医药杂志, 2016, 20(19):37-43. [7] 郝帅, 田武国, 高博,等. 循环肿瘤细胞检测在乳腺癌新辅助化疗疗效评估中的价值[J].中华乳腺病杂志:电子版, 2017, 11(1):6-12. [8] 李晓琴, 姬发祥, 林明哲,等. 多西他赛联合奥沙利铂治疗晚期胃癌的临床观察[J].现代肿瘤医学, 2011, 19(12):2498-2500. |
|
|
|